+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Supplement 1. Epidemiology, Pathogenesis, and Prevention of Haemophilus influenzae Disease || Safety, Immunogenicity, and Efficacy in Infancy of Oligosaccharide Conjugate Haemophilus influenzae Type b Vaccine in a United States Population: Possible Implications for Optimal Use



Supplement 1. Epidemiology, Pathogenesis, and Prevention of Haemophilus influenzae Disease || Safety, Immunogenicity, and Efficacy in Infancy of Oligosaccharide Conjugate Haemophilus influenzae Type b Vaccine in a United States Population: Possible Implications for Optimal Use



Journal of Infectious Diseases 165: S139-S143




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062266991

Download citation: RISBibTeXText

DOI: 10.2307/30112315


Related references

Safety, immunogenicity, and efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b vaccine in a United States population: possible implications for optimal use. Journal of Infectious Diseases 165(Suppl. 1): S139-S143, 1992

Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide Crm197 conjugate vaccine in a large defined United States population. The Pediatric Infectious Disease Journal 14(11): 978-981, 1995

Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-up. Pediatric Infectious Disease Journal 14(11): 978-981, 1995

Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61 080 children. Pediatric Infectious Disease Journal 10(2): 97-103, 1991

Supplement 1. Epidemiology, Pathogenesis, and Prevention of Haemophilus influenzae Disease || Maternal Immunization with the Capsular Polysaccharide Vaccine for Haemophilus influenzae Type b. Journal of Infectious Diseases 165: S134-S136, 1992

Supplement 1. Epidemiology, Pathogenesis, and Prevention of Haemophilus influenzae Disease || Finnish Efficacy Trials with Haemophilus influenzae Type b Vaccines. Journal of Infectious Diseases 165: S137-S138, 1992

Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group. Pediatric Infectious Disease Journal 11(8): 610-613, 1992

Supplement 1. Epidemiology, Pathogenesis, and Prevention of Haemophilus influenzae Disease || Preparation, Antigenicity, and Immunogenicity of Synthetic Ribosylribitol Phosphate Oligomer-Protein Conjugates and Their Potential Use for Vaccination against Haemophilus influenzae Type b Disease. Journal of Infectious Diseases 165: S152-S155, 1992

Efficacy in infancy of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. Pediatric Infectious Disease Journal 10(2): 97, 1991

Safety and immunogenicity of oligosaccharide conjugate haemophilus influenzae type b hboc vaccine in infancy. Pediatric Infectious Disease Journal 10(2): 92-96, 1991

Supplement 1. Epidemiology, Pathogenesis, and Prevention of Haemophilus influenzae Disease || The P6 Outer Membrane Protein of Nontypeable Haemophilus influenzae as a Vaccine Antigen. Journal of Infectious Diseases 165: S203-S205, 1992

Supplement 1. Epidemiology, Pathogenesis, and Prevention of Haemophilus influenzae Disease || G2m(23) Immunoglobulin Allotype and Immunity to Haemophilus influenzae Type b. Journal of Infectious Diseases 165: S66-S69, 1992

Supplement 1. Epidemiology, Pathogenesis, and Prevention of Haemophilus influenzae Disease || The Biology of Haemophilus influenzae Type b Vaccination Failure. Journal of Infectious Diseases 165: S121-S128, 1992

Supplement 1. Epidemiology, Pathogenesis, and Prevention of Haemophilus influenzae Disease || Comparison of Hemagglutinating Pili of Type b and Nontypeable Haemophilus influenzae. Journal of Infectious Diseases 165: S105-S106, 1992

Supplement 1. Epidemiology, Pathogenesis, and Prevention of Haemophilus influenzae Disease || Serum C-Reactive Protein in the Course of Haemophilus influenzae Type b Meningitis. Journal of Infectious Diseases 165: S36-S37, 1992